Fast Five Quiz: Can You Identify, Diagnose, and Treat HER2-Positive Gastric Cancer?

Maurie Markman, MD

May 31, 2024

Gastric cancer (GC) is one of the leading causes of cancer-related death in the world. Often seen in older patients, GC of all kinds is often diagnosed late, limiting options for treatment. Human epidermal growth factor receptor 2 (HER2) overexpression or amplification occurs in about 15%-20% of all GC cases. Targeted therapy against HER2-positive GC improves prognosis, yet mortality rates remain high.

Are you aware of the latest standards for how to identify, diagnose, manage, and treat HER2-positive GC? Test your knowledge with this quick quiz.

1 2 3 4 5 6

Next Section

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Maurie Markman. Fast Five Quiz: Can You Identify, Diagnose, and Treat HER2-Positive Gastric Cancer? - Medscape - May 31, 2024.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.